医学
肝硬化
重症监护医学
普通外科
梅德林
内科学
政治学
法学
出处
期刊:JAMA
[American Medical Association]
日期:2023-09-12
卷期号:330 (10): 969-969
标识
DOI:10.1001/jama.2023.11878
摘要
To the Editor I believe that the recent Review1 about the diagnosis and management of cirrhosis wrongly promoted off-label use of hydroxyzine in its abstract by mentioning “[t]rials addressing symptoms of cirrhosis have demonstrated efficacy for hydroxyzine in improving sleep dysfunction….”
科研通智能强力驱动
Strongly Powered by AbleSci AI